British Journal of Haematology · 1989 · 28 citations · 12 references
MedicineHematologyPharmacologyGlycobiologyHemostasisVascular SurgeryAnticoagulant TherapyAnticoagulation TherapyHemostatic AgentsThrombosisBleedingDermatan SulfateGlycosaminoglycansHeparan Sulfate-mediated AnticoagulationJugular VeinsRabbit ModelsSulfation PatternsVenous Thrombus Formation
We recently reported that the in vitro anticoagulant activities of dermatan sulphate and heparan sulphate were improved with increased sulphation. In this study we determined how the degree of sulphation of glycosaminoglycans influences their antithrombotic and bleeding effects in vivo. We compared the antithrombotic effects of each glycosaminoglycan by measuring their ability to inhibit experimentally-induced thrombus formation in rabbit jugular veins. The bleeding effect of each glycosaminoglycan was measured by comparing their ability to increase the amount of 51Cr-blood lost from five standardized cuts in rabbit ears. Increased sulphation only improved the antithrombotic effects of dermatan sulphate and heparan sulphate. In contrast, increased sulphation enhanced the blood loss associated with all the glycosaminoglycans evaluated. We conclude that the antithrombotic effects of heparan sulphate and dermatan sulphate can be enhanced by increased sulphation, but that the improved antithrombotic effects are compromised by the concomitant increase in bleeding side-effects.
12
CJ Carter, JG Kelton, J. Hirsh et al. · Blood · 1982 · 334 citations · Full text
Medicine, Biochemistry, Hemostasis +11
David Chas. Schechter · Diseases of the Chest · 1969 · 304 citations
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect
F. Fernandez, Philip V. Nguyen, Joanne van Ryn et al. · Thrombosis Research · 1986 · 140 citations
Medicine, Hematology, Pathology +13